(Q36530176)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16827596%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

review article

1 reference

title

Novel treatment options for inflammatory bowel disease: targeting alpha 4 integrin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16827596%20AND%20SRC:MED&resulttype=core&format=json

inflammatory bowel diseases

26 December 2019

main subject

0 references

author

Rubina Chaudhary

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16827596%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Francesco Lanzarotto

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16827596%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Marta Carpani

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16827596%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Subrata Ghosh

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16827596%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

publication date

1 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16827596%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16827596%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

66

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16827596%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16827596%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

1179-1189

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16827596%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00003495-200666090-00002

26 December 2019

exact match

0 references

cites work

Review article: is clinical remission the optimum therapeutic goal in the treatment of Crohn's disease?

1 reference

12 December 2020

Rapid resolution of chronic colitis in the cotton-top tamarin with an antibody to a gut-homing integrin alpha 4 beta 7

1 reference

12 December 2020

Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease

1 reference

12 December 2020

A pilot study of treatment of active ulcerative colitis with natalizumab, a humanized monoclonal antibody to alpha-4 integrin

1 reference

12 December 2020

Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial

1 reference

12 December 2020

The immunological and genetic basis of inflammatory bowel disease

1 reference

12 December 2020

The accessory function of murine intercellular adhesion molecule-1 in T lymphocyte activation. Contributions of adhesion and co-activation

1 reference

12 December 2020

Endoscopic and histologic healing of Crohn's (ileo-) colitis with azathioprine

1 reference

12 December 2020

Lymphocyte homing and homeostasis

1 reference

12 December 2020

Acquired increase in leucocyte binding by intestinal microvascular endothelium in inflammatory bowel disease

1 reference

12 December 2020

A randomized placebo-controlled trial of a humanized monoclonal antibody to alpha4 integrin in active Crohn's disease.

1 reference

12 December 2020

Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis

1 reference

12 December 2020

Progressive multifocal leukoencephalopathy in transplant recipients

1 reference

12 December 2020

Attenuation of colitis in the cotton-top tamarin by anti-alpha 4 integrin monoclonal antibody

1 reference

12 December 2020

Natalizumab Induction and Maintenance Therapy for Crohn's Disease

1 reference

12 December 2020

Progressive multifocal leukoencephalopathy in a patient treated with natalizumab

1 reference

12 December 2020

Expression of vascular adhesion molecules in inflammatory bowel disease

1 reference

12 December 2020

Natalizumab for active Crohn's disease

1 reference

12 December 2020

A placebo-controlled trial of ICAM-1 antisense oligonucleotide in the treatment of Crohn's disease

1 reference

12 December 2020

Mechanisms underlying neutrophil adhesion to apical epithelial membranes

1 reference

12 December 2020

Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm

1 reference

12 December 2020

Absence of efficacy of subcutaneous antisense ICAM-1 treatment of chronic active Crohn's disease

1 reference

12 December 2020

A randomised, controlled, double blind, escalating dose study of alicaforsen enema in active ulcerative colitis

1 reference

12 December 2020

Humanization of a mouse antibody against human alpha-4 integrin: a potential therapeutic for the treatment of multiple sclerosis

1 reference

12 December 2020